Ben Brzezynski

Head of Commercial
MindfulGarden Digital Health Inc.​
​​

Ben Brzezynski is a healthcare innovator and technology commercialization expert, having developed go-to-market strategies and led commercialization programs for innovative medical device, digital health and software companies in Canada, the United States and the United Kingdom. Ben was an early employee in the pioneering medical artificial intelligence (AI) company Enlitic, where he was Director of Business Development, bringing AI solutions for medical imaging diagnostics and workflow to markets in the USA, Japan and Europe. Ben has since held additional commercial leadership roles in global healthcare AI and IT companies ThinkSono AI (AI-powered diagnostics for blood clots), Dova Health Intelligence (AI-powered gastrointestinal disease assessment) and Cortico Health Technologies (electronic medical record automation and workflow enhancement). As a principal in the commercial advisory firm Growth Link Corp., Ben has advised many startups and technology companies on new market development and access, leading Canadian firms into international markets, and working with international firms assessing the Canadian market. Since joining the leadership team at MindfulGarden Digital Health in 2024, Ben has been responsible for designing and launching the company’s evaluation-to-sales model in Canada, preparing the company for USA market entry, and assessing and developing relationships in new markets in Asia. Ben works closely with the MindfulGarden product team to develop clinical and commercial value propositions that are based on the company’s leading clinical and economic research into the impact of biofeedback and dynamic nature-based digital imagery on delirium and dementia patients in hospital and long term care settings. Ben’s primary focus is to make MindfulGarden the global “tool of first reach” for managing delirium patients without the use of drugs or restraints.
 

Speech title & Synopsis

The Power of Biofeedback to Restore Calm 

This speech will explore the intersection of technology, design, and healthcare through the lens of MindfulGarden’s groundbreaking work in sensor-based biofeedback for managing agitation and delirium in hospitalized patients.
The speech will begin with an overview of MindfulGarden’s journey - starting with the founders’ early inspiration from personal experiences of the healthcare system and their previous careers delivering interactive design experiences to the entertainment industry. These early insights were shaped into a product concept under the guidance of a leading Canadian gerontology nurse and gerontology researcher, and refined with direct feedback from frontline care staff in long-term care, geriatric care and ICU settings.
The core of the talk will focus on the foundations, practices and peer-reviewed research that have inspired biofeedback interventions as a non-pharmacological alternative to restraints and sedatives in high-acuity care. The ethos of this solution area is rooted in biophilic design, employing exposure to nature to promote calm, reduce stress and improve recovery rates. We will review learnings from Roger Ulrich’s foundational 1984 research showing that hospital patients with views of nature required less pain medication and had shorter stays, to more recent studies on the effects of therapeutic hospital gardens, virtual nature in the ICU, and calming sound interventions for delirium management.
The talk will summarize by describing how these evidence-based principles have been incorporated into a clinically validated medical device - a dynamic and immersive digital healing experience that adapts in real time in response to patient behavior. A summary of MindfulGarden’s clinical and economic validation data will be provided for context.
Overall, this speech aims to inspire new thinking about how digital health, nature-inspired design, and biofeedback can come together to restore calm, safety, healing and dignity in the clinical environment.